hotspot -WSS

hotspot

author：hotspot 2025-10-02 00:29:21 - browse：73

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： 6 solutions to address cancer drug shortages and others

WSS

White House launches permanent pandemic office

Some top drug companies are starting to take action on climate

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Russian special forces kill a gunman who broke into a private house near Moscow

New rules on organ donation and transplantation 'will bring chaos'

7 of the most gruesome medical devices in history

focus

hotspot

entertainment

BioMarin wins approval for gene therapy to treat hemophilia A

Some top drug companies are starting to take action on climate

Tori Bowie and the unacceptable rates of Black maternal death

How artificial intelligence is being used to detect, treat cancer

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What will Novo Nordisk's VC do with its influx of cash?

DIEP, the 'gold standard' of breast reconstruction, is under threat

In new study, freeze

Bright Health sells Medicare Advantage business to Molina

What to know about Saharan dust affecting the US and how it can affect health

knowledge

What to know about Saharan dust affecting the US and how it can affect health

Nobel honors Karikó and Weissman's enduring partnership

Medicare innovation center doesn’t save money, experts say

Review: 'Barbie' will hit you like a shot in the heart

Study points to new risk in gene therapy death of Terry Horgan

What will Novo Nordisk's VC do with its influx of cash?

focus

knowledge

Wikipedia

focus